Luis Abreu

493 total citations
19 papers, 331 citations indexed

About

Luis Abreu is a scholar working on Surgery, Epidemiology and Genetics. According to data from OpenAlex, Luis Abreu has authored 19 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 9 papers in Epidemiology and 8 papers in Genetics. Recurrent topics in Luis Abreu's work include Inflammatory Bowel Disease (8 papers), Microscopic Colitis (6 papers) and Liver Diseases and Immunity (3 papers). Luis Abreu is often cited by papers focused on Inflammatory Bowel Disease (8 papers), Microscopic Colitis (6 papers) and Liver Diseases and Immunity (3 papers). Luis Abreu collaborates with scholars based in Spain and United States. Luis Abreu's co-authors include José Luís Calleja, Guillermo Cacho, P Escartín, María Isabel Vera-Muñoz, Yago González‐Lama, Alberto Herreros de Tejada, Agustı́n Albillos, Fernando García López, Jesús Espinel and Virginia Pertejo and has published in prestigious journals such as Hepatology, Journal of Hepatology and World Journal of Gastroenterology.

In The Last Decade

Luis Abreu

18 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luis Abreu Spain 9 191 127 119 118 99 19 331
Jean-Christophe Valats France 11 251 1.3× 116 0.9× 153 1.3× 60 0.5× 75 0.8× 17 369
Alexis Grucela United States 10 175 0.9× 58 0.5× 37 0.3× 83 0.7× 93 0.9× 21 273
Lars Karlsen Norway 8 67 0.4× 220 1.7× 50 0.4× 112 0.9× 114 1.2× 19 432
Elia Armellini Italy 15 261 1.4× 170 1.3× 172 1.4× 85 0.7× 253 2.6× 25 496
Kristine Wiencke Norway 9 103 0.5× 99 0.8× 63 0.5× 51 0.4× 30 0.3× 17 283
Ellen Viktil Norway 6 107 0.6× 78 0.6× 103 0.9× 48 0.4× 44 0.4× 12 283
Andrea Resegotti Italy 10 174 0.9× 134 1.1× 40 0.3× 191 1.6× 102 1.0× 26 357
Ottaviano Tarantino Italy 6 134 0.7× 222 1.7× 63 0.5× 261 2.2× 78 0.8× 8 378
Paul J. Kingma Netherlands 4 315 1.6× 276 2.2× 240 2.0× 89 0.8× 41 0.4× 8 553
Howard Smart United Kingdom 10 320 1.7× 121 1.0× 77 0.6× 55 0.5× 248 2.5× 31 471

Countries citing papers authored by Luis Abreu

Since Specialization
Citations

This map shows the geographic impact of Luis Abreu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Abreu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Abreu more than expected).

Fields of papers citing papers by Luis Abreu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis Abreu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Abreu. The network helps show where Luis Abreu may publish in the future.

Co-authorship network of co-authors of Luis Abreu

This figure shows the co-authorship network connecting the top 25 collaborators of Luis Abreu. A scholar is included among the top collaborators of Luis Abreu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis Abreu. Luis Abreu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Abreu, Luis & Alison Conway. (2021). A Qualitative Assessment of the Multimodal Passenger Transportation System Response to COVID-19 in New York City. Transportation Research Record Journal of the Transportation Research Board. 2677(4). 92–104. 6 indexed citations
2.
Abreu, Luis, et al.. (2017). Capsule endoscopy: Diagnosis of lobular capillary haemangioma. Gastroenterología y Hepatología (English Edition). 40(6). 403–404. 1 indexed citations
3.
González‐Lama, Yago, Cristina Suárez-Mejías, Marta Calvo, et al.. (2016). Impacto de la incorporación de la enfermera a una unidad de enfermedad inflamatoria intestinal. Gastroenterología y Hepatología. 39(5). 318–323. 5 indexed citations
4.
Calvo, Marta, et al.. (2016). Collagenous Colitis Refractory to Budesonide: is the Upper Gastrointestinal Tract Involved?. Journal of Crohn s and Colitis. 11(3). jjw150–jjw150.
5.
Abreu, Luis, et al.. (2016). Jejunitis secondary to Duodopa® probe, a different complication.. PubMed. 108(12). 815–816. 3 indexed citations
6.
González‐Lama, Yago, Cristina Suárez-Mejías, Marta Calvo, et al.. (2016). Impact of the incorporation of a nurse in an inflammatory bowel disease unit. Gastroenterología y Hepatología (English Edition). 39(5). 318–323. 3 indexed citations
7.
González‐Lama, Yago, Cristina Suárez-Mejías, Marta Calvo, et al.. (2015). Timing of Thiopurine or Anti-TNF Initiation Is Associated with the Risk of Major Abdominal Surgery in Crohn’s Disease: A Retrospective Cohort Study. Journal of Crohn s and Colitis. 10(1). 55–60. 25 indexed citations
8.
Calleja, José Luís, Antonio Hervás, Luis Abreu, et al.. (2015). A randomized trial to compare the efficacy and tolerability of sodium picosulfate-magnesium citrate solution vs. 4 L polyethylene glycol solution as a bowel preparation for colonoscopy. International Journal of Colorectal Disease. 30(10). 1407–1416. 9 indexed citations
9.
Tejada, Alberto Herreros de, et al.. (2014). Severe splenic rupture after colorectal endoscopic submucosal dissection. World Journal of Gastroenterology. 20(28). 9618–9620. 8 indexed citations
10.
González‐Lama, Yago, et al.. (2014). Mucosal healing in Crohn's disease: relevance and controversies in real life clinical practice.. PubMed. 106(7). 459–66. 2 indexed citations
11.
Mendoza, Juan L., Yago González‐Lama, Carlos Taxonera, et al.. (2012). Using of magnetic resonance enterography in the management of Crohn's disease of the small intestine: First year of experience. Revista Española de Enfermedades Digestivas. 104(11). 578–583. 16 indexed citations
12.
Fortea, José Ignacio, Yago González‐Lama, María Chaparro, et al.. (2011). Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experience. Gastroenterología y Hepatología. 34(7). 443–448. 19 indexed citations
13.
Bermejo, Pedro Emilio, et al.. (2009). Acquired chronic hepatocerebral degeneration due to cirrhosis from non-alcoholic steatohepatitis. Revista Española de Enfermedades Digestivas. 101(11). 806–11. 1 indexed citations
14.
Tejada, Alberto Herreros de, José Luís Calleja, Virginia Pertejo, et al.. (2009). Double-guidewire technique for difficult bile duct cannulation: a multicenter randomized, controlled trial. Gastrointestinal Endoscopy. 70(4). 700–709. 100 indexed citations
16.
González‐Lama, Yago, Luis Abreu, María Isabel Vera-Muñoz, et al.. (2005). Long-term Oral Tacrolimus Therapy in Refractory to Infliximab Fistulizing Crohnʼs Disease.. Inflammatory Bowel Diseases. 11(1). 8–15. 55 indexed citations
17.
Calleja, José Luís, Agustı́n Albillos, Guillermo Cacho, et al.. (1996). Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies. Journal of Hepatology. 24(3). 308–312. 45 indexed citations
18.
Álvarez‐Mon, Melchor, J Giron, Luís Manzano, et al.. (1994). Increased IgM B cell differentiation lymphokine production by T lymphocytes from patients with primary biliary cirrhosis. Journal of Hepatology. 20(4). 446–453. 10 indexed citations
19.
Giron, J, Luís Manzano, Luis Abreu, et al.. (1992). Deficient Interleukin–2 Responsiveness of T Lymphocytes From Patients With Primary Biliary Cirrhosis. Hepatology. 16(4). 931–936. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026